<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>Best Of Week - Head &amp; Neck Cancer</title>
    <link>https://pubmed.ncbi.nlm.nih.gov</link>
    <description>Top 10 most impactful head and neck cancer papers this week, selected by AI</description>
    <lastBuildDate>Fri, 06 Feb 2026 06:42:21 +0000</lastBuildDate>
    <item>
      <title>#1 [75/100] Thyroidectomy Outcomes in Older Adults: A Systematic Review and Meta-Analysis.</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41642589/</link>
      <guid>https://pubmed.ncbi.nlm.nih.gov/41642589/</guid>
      <dc:creator>Ghani A, Ayesh AR, Rajaram H, Ganegoda SM, Alogakos M, Sato A, Hage K, Than CA, Nakanishi H, Shin J, et al.</dc:creator>
      <pubDate>Thu, 05 Feb 2026 12:00:00 +0000</pubDate>
      <description>&lt;h3&gt;âœ¨ NOTABLE - Score: 75/100&lt;/h3&gt;&lt;p&gt;&lt;b&gt;Why this matters:&lt;/b&gt; This systematic review and meta-analysis addresses an important clinical question regarding thyroidectomy safety in older adults, with implications for risk assessment and patient counseling, and is published in a reputable journal. However, it does not present new primary data or a randomized controlled trial, which limits its potential impact.&lt;/p&gt;&lt;hr/&gt;&lt;b&gt;Authors:&lt;/b&gt; Ghani A, Ayesh AR, Rajaram H, Ganegoda SM, Alogakos M, Sato A, Hage K, Than CA, Nakanishi H, Shin J, et al.&lt;br/&gt;&lt;b&gt;Journal:&lt;/b&gt; JAMA otolaryngology-- head &amp; neck surgery | &lt;b&gt;DOI:&lt;/b&gt; &lt;a href='https://doi.org/10.1001/jamaoto.2025.5345'&gt;10.1001/jamaoto.2025.5345&lt;/a&gt;&lt;br/&gt;&lt;b&gt;Published:&lt;/b&gt; 2026-Feb-05&lt;br/&gt;&lt;b&gt;PMID:&lt;/b&gt; &lt;a href='https://pubmed.ncbi.nlm.nih.gov/41642589/'&gt;41642589&lt;/a&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;b&gt;Abstract:&lt;/b&gt;&lt;br/&gt;IMPORTANCE: A greater proportion of older patients (age â‰¥65 years) are undergoing thyroidectomy amidst an aging population. Given the elusive results in the literature, clarifying whether older patients face different thyroidectomy safety profiles is crucial for optimizing risk assessment and patient counseling. OBJECTIVE: To evaluate the association between older age (age â‰¥65 years) and thyroidectomy safety by comparing endocrine-related complications, including recurrent laryngeal nerve injury, hypocalcemia, hematoma, and mortality in older compared with younger patients. DATA SOURCES: Ovid MEDLINE, CINAHL, Ovid Embase, and the Cochrane Library were systematically searched from inception to May 29, 2025; only English-language studies were included. STUDY SELECTION: Cohort studies comparing thyroidectomy outcomes between older and younger patients and reporting endocrine-related complications were included. Two independent reviewers screened abstracts and full texts. Of 3192 studies identified, 11 met inclusion criteria. DATA EXTRACTION AND SYNTHESIS: Two independent reviewers extracted data following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Risk of bias across studies was evaluated using the ROBINS-I (Risk of Bias in Nonrandomized Studies of Interventions) tool. Random-effects models were used to pool data. MAIN OUTCOMES AND MEASURES: Incidence of recurrent laryngeal nerve injury, hypocalcemia, and hematoma; odds ratios (ORs) with 95% CIs were calculated. RESULTS: The analysis included 11 studies with a total of 427â€¯886 patients of whom 104â€¯232 (24.4%) were older adults (â‰¥65 years). Older adults had greater odds of overall recurrent laryngeal nerve injury (2.3% vs 1.0%; OR, 1.58; 95% CI, 1.15-2.16; I2â€‰=â€‰76%), hematoma (2.4% vs 1.0%; OR, 2.32; 95% CI, 1.70-3.16; I2â€‰=â€‰0%), and mortality at last follow-up (0.3% vs 0.01%; OR, 11.09; 95% CI, 1.77-69.52; I2â€‰=â€‰90%) compared with younger patients. However, rates of overall hypocalcemia (OR, 0.80; 95% CI, 0.61-1.05; I2â€‰=â€‰71%) and wound complications (OR, 1.38; 95% CI, 0.92-2.06; I2â€‰=â€‰0%) were similar. CONCLUSIONS AND RELEVANCE: This systematic review and meta-analysis found that thyroidectomy is safe in older patients, with only small absolute increases in recurrent laryngeal nerve injury, hematoma, and mortality despite statistical significance. These findings support individualized counseling and perioperative planning while acknowledging the overall safety of thyroidectomy in this population.</description>
    </item>
    <item>
      <title>#2 [75/100] Time to act: a global call for oral cancer prevention and early detection.</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41643692/</link>
      <guid>https://pubmed.ncbi.nlm.nih.gov/41643692/</guid>
      <dc:creator>Maret D, Warnakulasuriya S, Epstein JB, Geeraerts T, Vigarios E</dc:creator>
      <pubDate>Sun, 01 Feb 2026 12:00:00 +0000</pubDate>
      <description>&lt;h3&gt;âœ¨ NOTABLE - Score: 75/100&lt;/h3&gt;&lt;p&gt;&lt;b&gt;Why this matters:&lt;/b&gt; The paper addresses a critical global health issue regarding oral cancer prevention and early detection, published in a high-impact journal, which may influence clinical practices and public health policies.&lt;/p&gt;&lt;hr/&gt;&lt;b&gt;Authors:&lt;/b&gt; Maret D, Warnakulasuriya S, Epstein JB, Geeraerts T, Vigarios E&lt;br/&gt;&lt;b&gt;Journal:&lt;/b&gt; The Lancet. Oncology | &lt;b&gt;DOI:&lt;/b&gt; &lt;a href='https://doi.org/10.1016/S1470-2045(25)00708-9'&gt;10.1016/S1470-2045(25)00708-9&lt;/a&gt;&lt;br/&gt;&lt;b&gt;Published:&lt;/b&gt; 2026-Feb-01&lt;br/&gt;&lt;b&gt;PMID:&lt;/b&gt; &lt;a href='https://pubmed.ncbi.nlm.nih.gov/41643692/'&gt;41643692&lt;/a&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;i&gt;No abstract available&lt;/i&gt;</description>
    </item>
    <item>
      <title>#3 [75/100] The impact of drains on surgical outcomes in thyroid surgery-a meta-analysis of randomised controlled trials.</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41622270/</link>
      <guid>https://pubmed.ncbi.nlm.nih.gov/41622270/</guid>
      <dc:creator>Al-Taie DS, Mughal Z, Lotfallah A, Fussey J, Deutsch P, Warner G, Daultrey CR, Ayshford C, Gupta KK</dc:creator>
      <pubDate>Sun, 01 Feb 2026 12:00:00 +0000</pubDate>
      <description>&lt;h3&gt;âœ¨ NOTABLE - Score: 75/100&lt;/h3&gt;&lt;p&gt;&lt;b&gt;Why this matters:&lt;/b&gt; This meta-analysis of randomized controlled trials addresses an important clinical question regarding the use of surgical drains in thyroid surgery, potentially influencing surgical practice, although it is published in a specialty journal rather than a top-tier one.&lt;/p&gt;&lt;hr/&gt;&lt;b&gt;Authors:&lt;/b&gt; Al-Taie DS, Mughal Z, Lotfallah A, Fussey J, Deutsch P, Warner G, Daultrey CR, Ayshford C, Gupta KK&lt;br/&gt;&lt;b&gt;Journal:&lt;/b&gt; European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery | &lt;b&gt;DOI:&lt;/b&gt; &lt;a href='https://doi.org/10.1007/s00405-026-10015-3'&gt;10.1007/s00405-026-10015-3&lt;/a&gt;&lt;br/&gt;&lt;b&gt;Published:&lt;/b&gt; 2026-Feb-01&lt;br/&gt;&lt;b&gt;PMID:&lt;/b&gt; &lt;a href='https://pubmed.ncbi.nlm.nih.gov/41622270/'&gt;41622270&lt;/a&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;b&gt;Abstract:&lt;/b&gt;&lt;br/&gt;IMPORTANCE: Thyroidectomy is a commonly performed procedure with potential complications such as haematoma and seroma, which can result in life-threatening airway obstruction. Surgical drains have traditionally been used to mitigate these risks, but their necessity is increasingly debated due to concerns over pain, infection, and prolonged hospitalisation. OBJECTIVE: To evaluate the benefits and risks of using surgical drains following thyroidectomy. This meta-analysis of randomised controlled trials aimed to compare postoperative surgical outcomes in adult patients undergoing thyroid surgery, managed with or without drains. DATA SOURCES: Five electronic databases (PubMed, EMBASE, Ovid Medline, EMCARE, and CINAHL) were systematically searched in August 2025 for articles published between January 1995 and August 2025. STUDY SELECTION: Randomised controlled trials (RCTs) comparing outcomes in patients undergoing thyroidectomy with and without drains were included. Of the initial 119 articles identified, 10 RCTs were included in the final analysis, representing 1,078 patients. DATA EXTRACTION AND SYNTHESIS: Pooled proportions were calculated and transformed using the Freeman-Tukey double arcsine method. The random-effects meta-analysis of proportions was then conducted using inverse variance weighting, with between-study variance (Ï„2) estimated via the DerSimonian and LairdÂ method. MAIN OUTCOMES AND MEASURES: Primary outcomes included haematoma and seroma rates; secondary outcomes were surgical site infection (SSI), return-to-theatre (RTT), postoperative pain, and length of stay (LOS). RESULTS: Pooled complication rates were: haematoma 1.6%, seroma 3.7%, SSI 2.5%, and RTT 0.2%. Drain use was not associated with significant differences in haematoma (pâ€‰=â€‰0.15), seroma (pâ€‰=â€‰0.64), or RTT (pâ€‰=â€‰0.22). However, SSI (4.2% vs. 0.5%, pâ€‰=â€‰0.01), LOS (mean difference [MD]â€‰=â€‰1.2Â days; pâ€‰&lt;â€‰0.0001), and pain (MDâ€‰=â€‰2.2; pâ€‰=â€‰0.001) were significantly higher in the drain group. CONCLUSIONS AND RELEVANCE: Routine placement of drains after all types of thyroidectomies does not significantly decrease the rates of haematoma, seroma, or recurrent laryngeal nerve injury, and is linked to higher rates of surgical site infection, pain, and length of stay. A selective, patient-specific approach to drain use is recommended.</description>
    </item>
    <item>
      <title>#4 [75/100] Safety and Efficacy of Endoscopic Thyroidectomy by Gasless Unilateral Axillary for Papillary Thyroid Carcinoma in Primary Hospitals.</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41612971/</link>
      <guid>https://pubmed.ncbi.nlm.nih.gov/41612971/</guid>
      <dc:creator>Wu K, Wei X, Lu M, Wei X</dc:creator>
      <pubDate>Fri, 30 Jan 2026 12:00:00 +0000</pubDate>
      <description>&lt;h3&gt;âœ¨ NOTABLE - Score: 75/100&lt;/h3&gt;&lt;p&gt;&lt;b&gt;Why this matters:&lt;/b&gt; This is a prospective, single-center randomized controlled trial comparing a novel surgical technique for papillary thyroid carcinoma, which may provide important insights into surgical efficacy and patient outcomes, though its single-center design limits generalizability.&lt;/p&gt;&lt;hr/&gt;&lt;b&gt;Authors:&lt;/b&gt; Wu K, Wei X, Lu M, Wei X&lt;br/&gt;&lt;b&gt;Journal:&lt;/b&gt; Head &amp; neck | &lt;b&gt;DOI:&lt;/b&gt; &lt;a href='https://doi.org/10.1002/hed.70187'&gt;10.1002/hed.70187&lt;/a&gt;&lt;br/&gt;&lt;b&gt;Published:&lt;/b&gt; 2026-Jan-30&lt;br/&gt;&lt;b&gt;PMID:&lt;/b&gt; &lt;a href='https://pubmed.ncbi.nlm.nih.gov/41612971/'&gt;41612971&lt;/a&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;b&gt;Abstract:&lt;/b&gt;&lt;br/&gt;OBJECTIVE: To compare the safety and surgical efficacy of endoscopic thyroidectomy by gasless unilateral axillary (ETGUA) with conventional open thyroidectomy in patients with papillary thyroid carcinoma (PTC). METHODS: This prospective, single-center, and randomized controlled trial included 196 patients with PTC who met the inclusion and exclusion criteria. Patients were randomly assigned in a 1:1 ratio to the ETGUA group (nâ€‰=â€‰98) or the open thyroidectomy group (nâ€‰=â€‰98). Complications within 30â€‰days, parathyroid function [intact parathyroid hormone (iPTH) and serum calcium], and short-term oncological outcomes were observed. Secondary outcomes included operative time, intraoperative blood loss, postoperative recovery, pain score, cosmetic satisfaction, and hospitalization cost. RESULTS: The ETGUA group had a significantly longer operative time than the open thyroidectomy group, less intraoperative blood loss, more postoperative drainage at postoperative day 1, as well as a shorter postoperative hospital stay (all pâ€‰&lt;â€‰0.05). At 1â€‰year postoperatively, surgical efficacy and oncological indicators such as the number of lymph nodes dissected, number of positive lymph nodes, stimulated thyroglobulin (sTg) level, and the proportion of patients receiving adjuvant radioactive iodine therapy were comparable between groups (pâ€‰&gt;â€‰0.05). The ETGUA group reported lower visual analog scale (VAS) pain scores and higher cosmetic satisfaction, though the total hospitalization cost was slightly higher (all pâ€‰&lt;â€‰0.05). The learning curve analysis indicated that operative time and intraoperative blood loss stabilized after approximately 30-40 cases. CONCLUSION: ETGUA demonstrates comparable safety and oncological efficacy to conventional open thyroidectomy in PTC patients.</description>
    </item>
    <item>
      <title>#5 [75/100] Lymph node colonization induces tissue remodeling via immunosuppressive fibroblast-myeloid cell niches supporting metastatic tolerance.</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41616773/</link>
      <guid>https://pubmed.ncbi.nlm.nih.gov/41616773/</guid>
      <dc:creator>Haist M, Baertsch MA, Reticker-Flynn NE, Lu G, Kempchen TN, Chu P, Vazquez G, Chen H, Sunwoo JB, Zhang W, et al.</dc:creator>
      <pubDate>Thu, 29 Jan 2026 12:00:00 +0000</pubDate>
      <description>&lt;h3&gt;âœ¨ NOTABLE - Score: 75/100&lt;/h3&gt;&lt;p&gt;&lt;b&gt;Why this matters:&lt;/b&gt; The study presents novel insights into the immunosuppressive mechanisms associated with lymph node colonization in head and neck cancer, utilizing advanced spatial proteomics and transcriptomics, which may have significant clinical implications for understanding metastasis and guiding future therapeutic strategies.&lt;/p&gt;&lt;hr/&gt;&lt;b&gt;Authors:&lt;/b&gt; Haist M, Baertsch MA, Reticker-Flynn NE, Lu G, Kempchen TN, Chu P, Vazquez G, Chen H, Sunwoo JB, Zhang W, et al.&lt;br/&gt;&lt;b&gt;Journal:&lt;/b&gt; Cancer cell | &lt;b&gt;DOI:&lt;/b&gt; &lt;a href='https://doi.org/10.1016/j.ccell.2026.01.003'&gt;10.1016/j.ccell.2026.01.003&lt;/a&gt;&lt;br/&gt;&lt;b&gt;Published:&lt;/b&gt; 2026-Jan-29&lt;br/&gt;&lt;b&gt;PMID:&lt;/b&gt; &lt;a href='https://pubmed.ncbi.nlm.nih.gov/41616773/'&gt;41616773&lt;/a&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;b&gt;Abstract:&lt;/b&gt;&lt;br/&gt;Lymph node (LN) colonization in cancer is linked to poor prognosis. Evidence suggests that LN colonization induces systemic immunosuppression, facilitating distant metastasis. We investigated LN-mediated immunosuppression in patients with head-and-neck cancer using spatial proteomics, spatial transcriptomics, and an in vivo model of melanoma LN metastasis. Both primary tumors and paired LNs of nodal-positive patients exhibit enhanced interferon-Î³ signaling and an enrichment of immunosuppressive myeloid cells and cancer-associated fibroblasts (CAFs). The spatial intersection of these myeloid-CAF-enriched niches with perifollicular T cell zones and LN follicles is linked to enhanced T cell dysfunction and Treg activation therein, thereby driving architectural LN remodeling. These immune suppressive changes extend to adjacent non-tumor-involved LN regions and nearby tumor-free LNs, but were not detected in LNs of non-cancer patients, reflecting a systemic effect that compromises anti-tumor immunity beyond the tumor-involved LN. Hence, our findings establish LN colonization as an active driver of systemic immunosuppression, facilitating metastatic progression.</description>
    </item>
    <item>
      <title>#6 [70/100] The prognostic significance of the 'Worst Pattern of Invasion' in oral cancers-an international collaborative multicentre analysis.</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41638055/</link>
      <guid>https://pubmed.ncbi.nlm.nih.gov/41638055/</guid>
      <dc:creator>Roy P, Weber MB, Gupta R, Kakkar A, Fonseca D, Bal M, Kamboj M, Anand N, Anila KR, Velusamy S, et al.</dc:creator>
      <pubDate>Tue, 03 Feb 2026 12:00:00 +0000</pubDate>
      <description>&lt;h3&gt;âœ¨ NOTABLE - Score: 70/100&lt;/h3&gt;&lt;p&gt;&lt;b&gt;Why this matters:&lt;/b&gt; This multicenter analysis of 1374 patients provides important insights into the prognostic significance of the Worst Pattern of Invasion in oral squamous cell carcinoma, with potential implications for clinical practice, although it is a retrospective study.&lt;/p&gt;&lt;hr/&gt;&lt;b&gt;Authors:&lt;/b&gt; Roy P, Weber MB, Gupta R, Kakkar A, Fonseca D, Bal M, Kamboj M, Anand N, Anila KR, Velusamy S, et al.&lt;br/&gt;&lt;b&gt;Journal:&lt;/b&gt; Oral oncology | &lt;b&gt;DOI:&lt;/b&gt; &lt;a href='https://doi.org/10.1016/j.oraloncology.2026.107874'&gt;10.1016/j.oraloncology.2026.107874&lt;/a&gt;&lt;br/&gt;&lt;b&gt;Published:&lt;/b&gt; 2026-Feb-03&lt;br/&gt;&lt;b&gt;PMID:&lt;/b&gt; &lt;a href='https://pubmed.ncbi.nlm.nih.gov/41638055/'&gt;41638055&lt;/a&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;b&gt;Abstract:&lt;/b&gt;&lt;br/&gt;Worst pattern of invasion (WPOI) has been evaluated in many single-institute cohorts. Our goal was to perform a large multicentre evaluation of WPOI as a prognostic marker in oral squamous cell carcinoma (OSCC). Retrospective pathology data was collated from 14 institutions and compared with clinical outcome in 1374 OSCC patients with upfront curative resection. Most cases were of oral tongue (nÂ =Â 645, 47%); T2 (33%) and N0 (59%). WPOI 1-3 frequency was 29.4%, WPOI 4 47% and WPOI 5 22%. On univariable analysis, the 3-year disease free survival (DFS) was 54.2% for WPOI 5 vs. 69.7% for WPOI 1-4 (pÂ &lt;Â 0.001). The locoregional control (LRC) was 68.9% vs 79.2% (pÂ =Â 0.001), and overall survival (OS) 68.4% vs 83.8% (pÂ &lt;Â 0.001). On multivariable Cox-regression in the entire cohort, WPOI 4 or 5 was strongly correlated with other known poor prognostic factors and not an independent predictor of OS (HR 1.10, 95% CI 0.92-1.52), LRC or DFS. However, in early-stage (pT1-2Â N0) patients treated with surgery alone without adjuvant radiotherapy, WPOI 5 was a robust independent predictor of DFS (HR 4.36, 95% CI 1.54-12.32, pÂ =Â 0.006), OS (HR 3.69, 95% CI 1.23-11.1, pÂ =Â 0.020) and LRC (HR 3.52, 95% CI 2.13-5.82, p &lt;0.001) after applying inverse probability weighting to correct for selection bias. Furthermore, in the entire cohort of early-stage patients, interaction modeling showed that adjuvant radiotherapy significantly reduces the risk for both DFS and LRC for those with WPOI-5 (Interaction pÂ =Â 0.002). Therefore, it may act as a predictive biomarker for the benefit of adjuvant radiotherapy. The prognostic and predictive role of WPOI-5 should be validated in prospective trials.</description>
    </item>
    <item>
      <title>#7 [70/100] Multi-institutional Normal Tissue Complication Probability (NTCP) Prediction Model for Mandibular Osteoradionecrosis: Results from the PREDMORN Study.</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41642169/</link>
      <guid>https://pubmed.ncbi.nlm.nih.gov/41642169/</guid>
      <dc:creator>Humbert-Vidan L, Hansen CR, Petit S, MuÃ±oz-Montplet C, Hueniken K, Mohamed ASR, Saunders DP, Patel V, Verduijn GM, Heemsbergen WD, et al.</dc:creator>
      <pubDate>Thu, 08 Jan 2026 12:00:00 +0000</pubDate>
      <description>&lt;h3&gt;âœ¨ NOTABLE - Score: 70/100&lt;/h3&gt;&lt;p&gt;&lt;b&gt;Why this matters:&lt;/b&gt; This multi-institutional retrospective study on a large cohort of 3928 patients provides important insights into the risk factors for mandibular osteoradionecrosis, which could influence clinical practice, although it lacks the prospective design of higher-impact studies.&lt;/p&gt;&lt;hr/&gt;&lt;b&gt;Authors:&lt;/b&gt; Humbert-Vidan L, Hansen CR, Petit S, MuÃ±oz-Montplet C, Hueniken K, Mohamed ASR, Saunders DP, Patel V, Verduijn GM, Heemsbergen WD, et al.&lt;br/&gt;&lt;b&gt;Journal:&lt;/b&gt; International journal of radiation oncology, biology, physics | &lt;b&gt;DOI:&lt;/b&gt; &lt;a href='https://doi.org/10.1016/j.ijrobp.2025.12.044'&gt;10.1016/j.ijrobp.2025.12.044&lt;/a&gt;&lt;br/&gt;&lt;b&gt;Published:&lt;/b&gt; 2026-Jan-08&lt;br/&gt;&lt;b&gt;PMID:&lt;/b&gt; &lt;a href='https://pubmed.ncbi.nlm.nih.gov/41642169/'&gt;41642169&lt;/a&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;b&gt;Abstract:&lt;/b&gt;&lt;br/&gt;PURPOSE: Mandibular osteoradionecrosis (ORN) is a severe late complication affecting patients with head and neck cancer (HNC) treated with radiation therapy (RT) that significantly impacts patients' quality of life and can require costly interventions. Although radiation dose is a key factor, other clinical and demographic risk factors also influence ORN development. Previous predictive models have primarily been single-institutional, limiting their generalizability. In this first analysis from the PREDMORN Consortium, we have aimed to reproduce existing statistical association and modeling analyses on the largest and most diverse mandibular ORN cohort worldwide to allow comparison with previous studies. METHODS AND MATERIALS: This retrospective multi-institutional study included 3928 patients with HNC (622 ORN cases) from 8 institutions. Clinical, demographic, and dosimetric variables were analyzed to develop a prediction model (any grade ORN vs no ORN) using forward stepwise logistic regression with correlation-based variable preselection. The ORN normal tissue complication probability (NTCP) model was developed on 80% of data from 6 institutions, tested on the remaining unseen 20%, and externally validated on a matched cohort (58 patients, 19 ORN cases) and a large population-based cohort (2687 patients, 215 ORN cases). RESULTS: Key predictors of ORN were D30%, V70Gy, pre-RT dental extractions, and smoking status. The ORN NTCP model demonstrated very good calibration on the population-based external cohort (Brier score, 0.077; Log Loss, 0.281). Model discrimination improved on a subcohort including oropharyngeal and locally advanced larynx/hypopharynx cancer cases only (AUC from 0.69 to 0.75 and from 0.65 to 0.67 on the matched and the population-based external cohorts, respectively). CONCLUSIONS: The PREDMORN NTCP model is the largest multi-institutional effort to date aimed at predicting ORN risk in patients with HNC using real-world data. The model demonstrated good generalizability when externally validated to a large population-based cohort. Our observations align with current guidelines and corroborate findings from smaller single-institution studies.</description>
    </item>
    <item>
      <title>#8 [65/100] Choice and Death: Analysis of Medical Assistance in Dying for Head and Neck Cancer in Ontario.</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41636338/</link>
      <guid>https://pubmed.ncbi.nlm.nih.gov/41636338/</guid>
      <dc:creator>Curry T, Wener E, Odell M, Caulley L, Ramchandani R, Grant A, Thavorn K, Lasso A, Kilty S</dc:creator>
      <pubDate>Wed, 04 Feb 2026 12:00:00 +0000</pubDate>
      <description>&lt;h3&gt;ðŸ“Œ SELECTED - Score: 65/100&lt;/h3&gt;&lt;p&gt;&lt;b&gt;Why this matters:&lt;/b&gt; This study provides important insights into the prevalence and characteristics of Medical Assistance in Dying for head and neck cancer patients, addressing a significant clinical question, but it is a retrospective analysis with a moderate sample size and lacks immediate clinical applicability in terms of treatment guidelines.&lt;/p&gt;&lt;hr/&gt;&lt;b&gt;Authors:&lt;/b&gt; Curry T, Wener E, Odell M, Caulley L, Ramchandani R, Grant A, Thavorn K, Lasso A, Kilty S&lt;br/&gt;&lt;b&gt;Journal:&lt;/b&gt; The Laryngoscope | &lt;b&gt;DOI:&lt;/b&gt; &lt;a href='https://doi.org/10.1002/lary.70410'&gt;10.1002/lary.70410&lt;/a&gt;&lt;br/&gt;&lt;b&gt;Published:&lt;/b&gt; 2026-Feb-04&lt;br/&gt;&lt;b&gt;PMID:&lt;/b&gt; &lt;a href='https://pubmed.ncbi.nlm.nih.gov/41636338/'&gt;41636338&lt;/a&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;b&gt;Abstract:&lt;/b&gt;&lt;br/&gt;OBJECTIVE: There is a paucity of information on the uptake of Medical Assistance in Dying (MAiD) for patients with head and neck cancer (HNC). Our study reports the prevalence, disease characteristics, and nature of the desire for MAiD in patients with HNC who underwent the process in Ontario. The aim is to better understand this population and identify gaps in our current system of care. METHODS: This is a retrospective cross-sectional analysis for the period June 17, 2016 to December 31, 2022. Data were received from the Office of the Chief Coroner Ontario, Canada. RESULTS: Three hundred and fifty-six persons received MAiD. The average age was 72.4â€‰years (SD 12.22) with 260 of the patients being men (73.03%). The most common HNC primary tumor site was the oral cavity 109 (30.6%). The most reported reason was inadequate control of symptoms other than pain (79.21%) followed by inadequate pain control or concerns about it (75%). The patient's private residence (55.62%) was the most common setting. Patients were more likely to live in wealthier neighborhoods and in large urban centers. Future prediction of MAiD uptake shows a linear year-by-year increase. CONCLUSION: The use of MAiD in HNC has been steadily increasing since its legalization and is projected to continue increasing. There is a male predominance that is aligned with the incidence and prevalence of HNC nationally. Overall, MAiD is an increasingly employed choice for HNC patients receiving treatment for disease without curative intent.</description>
    </item>
    <item>
      <title>#9 [65/100] Role of nutritional (PNI, CONUT) and inflammatory indices (SII) in predicting lymph node metastasis and prognosis of thyroid cancer: a systematic review and meta-analysis.</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41634408/</link>
      <guid>https://pubmed.ncbi.nlm.nih.gov/41634408/</guid>
      <dc:creator>Liu Y, Xiao R</dc:creator>
      <pubDate>Tue, 03 Feb 2026 12:00:00 +0000</pubDate>
      <description>&lt;h3&gt;ðŸ“Œ SELECTED - Score: 65/100&lt;/h3&gt;&lt;p&gt;&lt;b&gt;Why this matters:&lt;/b&gt; This systematic review and meta-analysis synthesizes data from multiple studies on nutritional and inflammatory indices in thyroid cancer, providing important insights into their prognostic value, but it lacks the robustness of large prospective studies or randomized controlled trials.&lt;/p&gt;&lt;hr/&gt;&lt;b&gt;Authors:&lt;/b&gt; Liu Y, Xiao R&lt;br/&gt;&lt;b&gt;Journal:&lt;/b&gt; European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery | &lt;b&gt;DOI:&lt;/b&gt; &lt;a href='https://doi.org/10.1007/s00405-025-09976-8'&gt;10.1007/s00405-025-09976-8&lt;/a&gt;&lt;br/&gt;&lt;b&gt;Published:&lt;/b&gt; 2026-Feb-03&lt;br/&gt;&lt;b&gt;PMID:&lt;/b&gt; &lt;a href='https://pubmed.ncbi.nlm.nih.gov/41634408/'&gt;41634408&lt;/a&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;b&gt;Abstract:&lt;/b&gt;&lt;br/&gt;PURPOSE: Markers reflecting systemic inflammation and nutritional condition are now often applied in predicting cancer outcomes, yet their role in thyroid malignancies has not been clearly established. We reviewed the evidence in the literature on the role of Prognostic Nutritional Index (PNI), Controlling Nutritional Status Score (CONUT), and Systemic Immune-Inflammation Index (SII) in predicting lymph node metastasis (LNM), overall survival (OS), and disease-free survival (DFS) in thyroid cancer. METHODS: Two reviewers searched CENTRAL, Embase, PubMed, and Scopus databases till 24th August 2025 for relevant publications. A random-effects meta-analysis was conducted. RESULTS: Thirteen studies were eligible. Combined results demonstrated that elevated SII was slightly but significantly correlated with increased risk of LNM (HR: 1.00; 95% CI: 1.00-1.01; IÂ² = 93%). Results failed to change in the sensitivity analysis. Subgroup analysis based on location and histology indicated non-significant results while meta-regression did not identify any significant moderators. Pooled analysis indicated no significant association between low PNI and DFS (HR: 1.45 95% CI: 0.97, 2.18 I2â€‰=â€‰80%) and LNM (HR: 1.31 95% CI: 0.89, 1.92 I2â€‰=â€‰73%) in thyroid cancer patients. Meta-analysis also showed that high CONUT was associated with a tendency of worse DFS in thyroid cancer, but results were non-significant (HR: 3.25 95% CI: 0.99, 10.69 I2â€‰=â€‰86%). However, meta-analysis showed that high CONUT was significantly associated with worse OS (HR: 9.67 95% CI: 1.90, 49.25 I2â€‰=â€‰61%). CONCLUSIONS: Limited data suggest that high SII may be marginally associated with increased risk of LNM in thyroid cancer, the clinical significance of which is questionable. PNI was not found to be associated with LNM or DFS in thyroid cancer patients. High CONUT was associated with poor OS and a non-significant tendency for worse DFS in thyroid cancer.</description>
    </item>
    <item>
      <title>#10 [65/100] The value of nasopharyngeal brush versus plasma EBV DNA detection in diagnosing local recurrence of nasopharyngeal carcinoma.</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41631491/</link>
      <guid>https://pubmed.ncbi.nlm.nih.gov/41631491/</guid>
      <dc:creator>Ouyang YF, Liang JL, Xie RQ, Liu YP, You R, Xia TL, Chen MY</dc:creator>
      <pubDate>Tue, 03 Feb 2026 12:00:00 +0000</pubDate>
      <description>&lt;h3&gt;ðŸ“Œ SELECTED - Score: 65/100&lt;/h3&gt;&lt;p&gt;&lt;b&gt;Why this matters:&lt;/b&gt; This study evaluates a novel diagnostic approach for detecting recurrence in nasopharyngeal carcinoma using EBV DNA, with a moderate sample size of 187 patients. While it provides important insights into surveillance methods, it does not represent a paradigm shift or practice-changing findings.&lt;/p&gt;&lt;hr/&gt;&lt;b&gt;Authors:&lt;/b&gt; Ouyang YF, Liang JL, Xie RQ, Liu YP, You R, Xia TL, Chen MY&lt;br/&gt;&lt;b&gt;Journal:&lt;/b&gt; International journal of cancer | &lt;b&gt;DOI:&lt;/b&gt; &lt;a href='https://doi.org/10.1002/ijc.70357'&gt;10.1002/ijc.70357&lt;/a&gt;&lt;br/&gt;&lt;b&gt;Published:&lt;/b&gt; 2026-Feb-03&lt;br/&gt;&lt;b&gt;PMID:&lt;/b&gt; &lt;a href='https://pubmed.ncbi.nlm.nih.gov/41631491/'&gt;41631491&lt;/a&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;b&gt;Abstract:&lt;/b&gt;&lt;br/&gt;Nasopharyngeal carcinoma (NPC) remains a major challenge due to the high incidence of recurrence, often leading to therapeutic failure. Early detection of recurrence is critical, yet effective surveillance methods are limited. This study aims to evaluate the utility of Epstein-Barr virus (EBV) DNA detection in nasopharyngeal brush samples for identifying recurrent NPC. A total of 187 NPC patients who had undergone radical radiotherapy with or without chemotherapy were included. EBV DNA levels in both nasopharyngeal brush and plasma samples were analyzed using real-time quantitative PCR. Head and neck MRI, sinus endoscopy examination, and biopsy of suspicious lesions were used as the gold standard to confirm recurrence. Patients without recurrence after more than 1â€‰year of follow-up served as controls. Nasopharyngeal brush EBV DNA detection demonstrated significantly higher sensitivity (95.7%) for detecting recurrence compared to plasma EBV DNA testing (61.4%), with comparable specificity (94.0% vs. 96.6%). The positive predictive value was similar between methods, whereas the negative predictive value was markedly higher for the nasopharyngeal brush group (97.3% vs. 80.7%). These findings suggest that EBV DNA detection in nasopharyngeal brush samples is a highly sensitive and minimally invasive supplementary tool for monitoring NPC recurrence. This approach offers superior sensitivity and an improved negative predictive value compared to plasma EBV DNA testing, and may enhance early surveillance and clinical management of NPC recurrence.</description>
    </item>
  </channel>
</rss>
